Status:
COMPLETED
Anti-stigma Intervention for Chinese American Older Adults
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Conditions:
Mood Disorders
Anxiety Disorders
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Approximately 50 participants will be enrolled and screened to achieve 45 eligible patients with mood/anxiety disorders to complete a 10 weekly anti-stigma group intervention (ASGI) in addition to sev...
Eligibility Criteria
Inclusion
- Self-reported Chinese heritage;
- 55 years or older
- Mandarin and/or Cantonese speaking and ability to read and/or comprehend spoken Chinese language.
- Currently receiving treatment from a mental health provider at Gouverneur Medical Center Asian Bicultural Clinic (GMC ABC) and willing to continue mental health care through the study.
- Willing to provide release for communication between primary mental health care provider and study staff throughout the study.
- Documented by mental health provider after consent for release of information as having mood and anxiety disorder diagnosis in the past year;
- A willingness to participate in the ASGI with stated availability;
- Able and willing to provide informed consent.
Exclusion
- Lifetime psychosis, neurocognitive, or significant neurological disorders;
- Current manic episode;
- Past 6 months of alcohol/substance use disorder;
- Serious safety concerns of suicide or homicide.
Key Trial Info
Start Date :
August 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2020
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03820297
Start Date
August 19 2019
End Date
March 13 2020
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016